The UK does not include Spain in its list of safe destinations

Government United kingdom This Friday, he announced a list of 12 countries and territories to which flights will be facilitated from May 17th, as they are considered safe destinations with regard to data. Coronavirus disease. However, the so-called “green list” He departed from Spain.

They will not have to quarantine

As detailed by the British Secretary of Transport, Grant Shaps, Those travelers returning to the country from the destinations that appear on the list (among them Portugal, Gibraltar, and Israel) They will not have to quarantine service ten days. Also, only one PCR test is required.

Those who come from Spain, will have to submit two PCRs

On the contrary, people who come from countries classified as amber will have to go through quarantine and must prove a negative result with two antigen tests.

At a press conference, Shaps reported that the rating will be revised three weeks after May 17, the date when the ban on overseas travel from the UK will be lifted.

As happened with the Spanish state, France and Greece They were also excluded from the list.

The patent release, under discussion

As countries prepare for the restrictions as the good weather approaches, the debate continues in the European Union over the possible suspension of Covid vaccine patents.

Last Thursday, President of the European Commission, Ursula von der Leyen, He indicated that the European Union is open to revoking patents on coronavirus vaccines. The possibility that he would initially gain the support of the French president, Emmanuel Macron. But he has now retracted, declaring patents “not a problem” getting vaccines.

Upon arriving at the Porto summit, which was being held to address this issue, Macron indicated that the problem is this Production capacity In this sense, he sees a “key” to promoting “technology transfer” between pharmaceutical companies.

Meanwhile, since then Spanish CEO In their view, “the exemption from patents alone is not sufficient to guarantee access to developing countries.” They noted that approval at the World Trade Organization (WTO) will take some time, a period that can range from six months to a year, and it is also imperative for pharmaceutical companies to be flexible to speed up the process.

“It is imperative to enhance the transfer of knowledge and technology, and to increase the global production of vaccines and distribute them around the world,” they point out from the CEO Pedro Sanchez.

Feature image, UK Prime Minister Boris Johnson / EFE